Company registration number: 09993255
Unaudited financial statements
for the year ended 31 March 2025
for
PharmaSEAL International Limited
Pages for filing with the Registrar
Company registration number: 09993255
PharmaSEAL International Limited
Balance sheet
as at 31 March 2025
2025 2024
Note £ £ £ £
Fixed assets
Tangible assets 4 2,203 3,305
2,203 3,305
Current assets
Debtors 128,152 194,130
Cash at bank and in hand 512,953 463,584
641,105 657,714
Creditors: amounts falling due within one
year
(533,614) (404,415)
Net current assets 107,491 253,299
Total assets less current liabilities 109,694 256,604
Creditors: Amounts falling due after more
than one year
5 (22,294) (27,018)
NET ASSETS 87,400 229,586
Capital and reserves
Called up share capital 6 5
Share premium account 2,693,908 2,723,204
Profit and loss account (2,606,514) (2,493,623)
TOTAL EQUITY 87,400 229,586
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 March 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 09993255
PharmaSEAL International Limited
Balance sheet - continued
as at 31 March 2025
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
These financial statements were approved by the Board of directors and authorised for issue on 6 October 2025 and signed on its behalf by:
Mr D Cheema, Director
6 October 2025
2
PharmaSEAL International Limited
Notes to the financial statements
for the year ended 31 March 2025
1 Company information
PharmaSEAL International Limited is a private company registered in England and Wales. Its registered number is 09993255. The company is limited by shares. Its registered office is Ingenuity Centre, Nottingham University Innovation Park, Nottingham, NG7 2TU.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the directors have assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company's ability to continue as a going concern. In making this assessment, the directors take into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The directors consider that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc.:
Fixtures & fittings - 33% reducing balance
Computer equipment - 33% reducing balance
Taxation
Taxation for the year comprises current taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
3
PharmaSEAL International Limited
Notes to the financial statements - continued
for the year ended 31 March 2025
2 Accounting policies - continued
Research and development
Expenditure on research and development is written off in the year in which it is incurred.
Retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit and loss in the period to which they relate.
3 Average number of employees
During the year the average number of employees was 8 (2024 - 8).
4 Tangible fixed assets
Plant and
machinery
etc.
£
Cost
At 1 April 2024 15,193
At 31 March 2025 15,193
Depreciation
At 1 April 2024 11,888
Charge for year 1,102
At 31 March 2025 12,990
Net book value
At 31 March 2025 2,203
At 31 March 2024 3,305
5 Creditors: amounts falling due after more than five years
2025 2024
£ £
Repayable by instalments
Bank loans 2,294 7,018
4